申请人:Ciufolini Marco A.
公开号:US20120053186A1
公开(公告)日:2012-03-01
Novel compounds selected from 2-(3-aminoaryl)amino-4-aryl-thiazoles of formula (I) that selectively modulate, regulate, and/or inhibit signal transductions mediated by certain native and/or mutant tyrosine kinases implicated in a variety of human and animal diseases such as cell proliferative metabolic, allergic and degenerative disorders. More particularly, these compounds are potent and selective c-kit inhibitors.
从公式(I)的2-(3-氨基芳基)氨基-4-芳基噻唑中选择的新化合物,可以选择性地调节、调控和/或抑制某些与多种人类和动物疾病相关的原生和/或突变酪氨酸激酶介导的信号转导,如细胞增殖代谢、过敏和变性性疾病。特别是,这些化合物是有效和选择性的c-kit抑制剂。